A paucity of co-infecting respiratory viral pathogens in nasopharyngeal specimens from patients infected with H274Y-positive influenza A (H1N1) strains.
Eshaghi
A
A
Blair
J
J
Burton
L
L
Lombos
E
E
Choi
K
K
De Lima
C
C
Drews
S J
SJ
D000998:Antiviral Agents / Q000494:pharmacology; D024882:Drug Resistance, Viral / Q000235:genetics; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000145:classification / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification*; D007251:Influenza, Human / Q000150:complications / Q000453:epidemiology / Q000821:virology; D009154:Mutation; D009305:Nasopharynx / Q000821:virology*; D009439:Neuraminidase / Q000235:genetics*; D009864:Ontario / Q000453:epidemiology; D053139:Oseltamivir / Q000494:pharmacology; D012141:Respiratory Tract Infections / Q000150:complications / Q000453:epidemiology / Q000821:virology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014764:Viral Proteins / Q000235:genetics*; D014777:Virus Diseases / Q000150:complications / Q000453:epidemiology / Q000821:virology; D014780:Viruses / Q000145:classification / Q000235:genetics / Q000302:isolation & purification*
D000998:Antiviral Agents; D014764:Viral Proteins; D053139:Oseltamivir; C487630:NA protein, influenza A virus; D009439:Neuraminidase